author-photo

Kevin Kao

Rockefeller University

4

Papers

116

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

The Card1 nuclease provides defence during type-III CRISPR immunity

2021 Nature
Show All
- Source
- Cite
- Save
Citations (12)
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy.

2021 Nature
Show All
- Source
- Cite
- Save
Citations (6)
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

2020 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (83)
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (15)